Cargando...
Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation
Mutations in the KRAS proto-oncogene are present in 50% of all colorectal cancers and are increasingly associated with chemotherapeutic resistance to frontline biologic drugs. Accumulating evidence indicates key roles for overactive KRAS mutations in the metabolic reprogramming from oxidative phosph...
Gardado en:
| Publicado en: | J Biol Chem |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Biochemistry and Molecular Biology
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6153299/ https://ncbi.nlm.nih.gov/pubmed/30087121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.RA117.001469 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|